Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hot Flashes × Estrogens, Conjugated (USP) × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Risk Reduction Behavior 1 Prostatic Neoplasms 1 Hot Flashes 1 Breast Neoplasms 1

Interventions

Venlafaxine Hydrochloride 2 Sodium Chloride 2 Magnesium Oxide 2 Gabapentin 2 Bupivacaine 2 fezolinetant 1 black cohosh root extract 1 bazedoxifene 1 Tamoxifen 1 Soybean Proteins 1 Solifenacin Succinate 1 Isoflavones 1 Hypericum extract LI 160 1 Estrogens, Conjugated (USP) 1 Estetrol 1 Daptomycin 1 Clonidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡